Sermorelin tablets are real products. 48 of the sellers listed on this site offer sermorelin by mouth — a tablet that dissolves under the tongue, a troche, an oral disintegrating tablet, a capsule — and 29 of them publish a monthly price for it, from $95 to $299. You can buy one this afternoon with a prescription. The question worth asking first is not where to get one. It is what is known about whether the route works, and the honest answer is short.
Have sermorelin tablets been tested in people?
Almost the entire adult evidence base for sermorelin is a single trial: nineteen adults aged 55 to 71, single-blind, placebo-controlled, five months, published in 1997 [1]. Every participant injected it subcutaneously. No part of that trial tested a tablet, a troche or a capsule, and what that trial actually measured is worth reading before weighing any format against it.
That leaves a specific question: has an oral or sublingual sermorelin product ever been studied in people? As of October 2026, PubMed indexes 333 records for sermorelin in total. Seven mention oral anything. One mentions sublingual, buccal or troche. Filtered to clinical trials, the sublingual search returns zero.
Both near-misses are worth naming, because a count on its own would mislead. The single sublingual-adjacent record is a 1997 paper on vasoactive intestinal polypeptide receptor mRNA in a cell line; it contains no sublingual sermorelin product. The single oral clinical trial is a 1987 study of pyridostigmine and growth hormone feedback — pyridostigmine is the oral drug in it, given alongside GHRH. Neither is a trial of a sermorelin tablet. The number of human trials of oral sermorelin is zero, and it is zero after reading the results rather than after counting them.
Why does the route matter for a peptide?
Sermorelin is a 29‑amino‑acid peptide. Peptides that size are ordinarily broken up by stomach acid and gut enzymes before they reach the bloodstream, which is why the approved product that once existed was an injection and why no approved sermorelin product is on the market today. Sublingual and buccal formulations exist precisely to route around the gut, and for some molecules they work. Whether they deliver a useful amount of this molecule is the thing nobody has published. PubMed returns four records for sermorelin and bioavailability, and none of them establishes a figure for a tablet.
A seller is not obliged to run a trial, and none selling a tablet has. What a reader can reasonably expect is that the price reflects the uncertainty. Mostly, it does not.
Are sermorelin tablets cheaper than injections?
Not reliably. The intuition is that skipping the needle should cost less. Of the 30 sellers here that price both formats in the same unit, 14 price the oral below the injection, 14 price them identically to the dollar, and 2 price the oral higher (EllieMD, $837 against $645; Try Ageless, $199 against $176).
So at 16 of 30 sellers, choosing the tablet saves nothing at all. Across the market, the median oral price is $159 a month against $179 for injections. The full seller-by-seller breakdown is in the pills vs. injections price comparison, and the oral sermorelin board ranks the sellers that publish a price for the format.
What is the difference between a tablet, a troche and an ODT?
Four words get used for the same shelf and they are not synonyms. A sublingual tablet dissolves under the tongue and is meant to absorb through the mucosa. A troche is a soft lozenge doing the same job in a different base. An ODT, or oral disintegrating tablet, dissolves in the mouth but is generally intended to be swallowed. A capsule is swallowed outright and goes through the stomach.
That last distinction is the one that matters most and the one sellers blur most often. A product designed to be swallowed faces the digestive problem head-on; a product designed to absorb under the tongue is at least attempting to avoid it. Several sellers list a product simply as “oral” without saying which. If you are choosing a format, that is a fair question to put to the prescriber, alongside the rest of the questions worth asking before you pay.
How do the four sermorelin formats compare?
Side by side, the formats differ less in price than in what has been tested. Sellers usually list tablets, troches and capsules together as “oral,” so they share a row.
| Format | Human trials | Sellers listed | Median monthly price |
|---|---|---|---|
| Injection (under the skin) | One placebo-controlled adult trial, n = 19 [1], plus pediatric trials | 171 | $179 |
| Sublingual tablet or ODT | None published | 48 (sold as “oral”) | $159 |
| Troche or capsule | |||
| Nasal spray | Two small 1993 studies of the same peptide: 3 to 5% absorbed in 30 healthy men [2]; abandoned in children [3] | 8 | $199 |
The nasal row is the only non-injected route with any human data, and it is not encouraging. In healthy men, only 3 to 5% of an intranasal dose was absorbed [2]. In a six-month pilot in eight children, the response faded, three developed antibodies and most reported nasal irritation; the authors concluded it was not suitable in that form [3]. Neither tested a product sold today.
What can a buyer actually act on?
If a needle is the obstacle, a tablet is a genuine option and it is prescribed and dispensed the same way — compounded, by prescription, from a licensed pharmacy. Nothing here says it does not work. It says nobody has shown that it does, that the one trial behind the whole category used injections, and that the format usually carries the same price as the route that was studied.
Two other oral products come up beside sermorelin tablets. One is a combination tablet, covered in what the sermorelin GHK-Cu tablet contains. The other, MK-677, is a pill that is not sermorelin at all; it is set against the injection in sermorelin vs. MK-677.
Those are three separate facts and a reader deserves all three before choosing. If price is the deciding factor, check that your seller actually discounts the oral form, because many do not.